Kwangdong to market new radiosensitizer in 2012

Published: 2008-06-24 06:41:00
Updated: 2008-06-24 06:41:00
Kwangdong Pharm says it has signed an exclusive lisensing agreement with China-based Shandong Luye Pharmaceutical (SDLY) to develop and market a novel radiosensitizer “CMNa” in Korea.

CMNa is a new nitroimidazole compound, which was designed and synthesized, and studied by Chinese scientists ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.